A Phase 1 Clinical Trial to Explore Systemic Exposure of CTO0101 Eye Drops, Safety and Local Tolerability in Healthy Adults
Clinical trial NCT05262179 · UNKNOWN
Trial details
- NCT number
- NCT05262179
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-05
- Primary completion
- 2022-05-27
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.